Burkhardt Glen

SVP of Human ResourcesPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4 · filed May 24, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 23, 2022Sell(S)11K$0.79$9K0
May 20, 2022Grant(A)11K$0.68$8K11K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001169245-22-000077) within minutes of acceptance. Every field above traces to the original document. Verify it directly: